Speaker
Dr
Anita Wolfer
(CHUV, Lausanne)
Description
Ovarian cancer is the 8th most common cancer in women and the 5th most common reason for cancer death. There is no recognized screening method and ovarian cancer is most often diagnosed at an advanced stage. I will give a short background on epidemiology of epithelial ovarian cancer as well as on its diagnosis and genetic background. Then, we will discuss current standard treatment which consists in surgery followed by platinum containing chemotherapy. And finally, we will also talk about new targeted therapies such as the PARP inhibitors that have brought new interesting treatment options to ovarian cancer patients at early as well as late stages. To conclude, we will also discuss immunotherapy for ovarian cancer.
Primary author
Dr
Anita Wolfer
(CHUV, Lausanne)
